Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Pagna Sok, Osaro Mgbere, Lisa Pompeii & Ekere James Essien. (2021) Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas. HIV/AIDS - Research and Palliative Care 13, pages 539-555.
Read now
Read now
Giovanni Guaraldi, Ines Pintassilgo, Jovana Milic & Cristina Mussini. (2018) Managing antiretroviral therapy in the elderly HIV patient. Expert Review of Clinical Pharmacology 11:12, pages 1171-1181.
Read now
Read now
Marco Ripa, Stefania Chiappetta & Giuseppe Tambussi. (2017) Immunosenescence and hurdles in the clinical management of older HIV-patients. Virulence 8:5, pages 508-528.
Read now
Read now
Mercedes Gimeno-Gracia, María José Crusells-Canales, Francisco Javier Armesto-Gómez, Vicente Compaired-Turlán & María José Rabanaque-Hernández. (2016) Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population. Clinical Interventions in Aging 11, pages 1149-1157.
Read now
Read now
Huda Taha, Archik Das & Satyajit Das. (2015) Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS. Infection and Drug Resistance 8, pages 339-352.
Read now
Read now
Articles from other publishers (20)
Ying Zhang, Mark Johnson, Samit Joshi, Parto Yazdani, Joyce Zhan, Bo Wen, Veronica Bainbridge, Martin Gartland & Max Lataillade. (2023) Open‐label, drug–drug interaction study between the HIV‐1 maturation inhibitor GSK3640254 and a metabolic probe cocktail in healthy participants. British Journal of Clinical Pharmacology 89:7, pages 2236-2245.
Crossref
Crossref
Juliana de Oliveira Costa, Stella Lau, Nicholas Medland, Sara Gibbons, Andrea L. Schaffer & Sallie‐Anne Pearson. (2022) Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia. British Journal of Clinical Pharmacology 89:5, pages 1541-1553.
Crossref
Crossref
Basavaraj Poojar, Ashok Shenoy K, Ashwin Kamath, John Ramapuram & Sathish B. Rao. (2023) Evaluation of health literacy and medication regimen complexity index among patients with human immunodeficiency virus infection: A single-Centre, prospective, cross-sectional study. Clinical Epidemiology and Global Health 19, pages 101206.
Crossref
Crossref
Mohammed Ibn-Mas’ud Danjuma, Safah Khan, Farah Wahbeh, Lina Mohammad Naseralallah, Unwam E. Jumbo & Abdelnaser Elzouki. (2022) What is polypharmacy in people living with HIV/AIDS? A systematic review. AIDS Research and Therapy 19:1.
Crossref
Crossref
Leah H. Rubin, Ava G. NeijnaQiuhu ShiDonald R. HooverBani TamrazKathryn AnastosAndrew EdmondsMargaret A. FischlDeborah GustafsonPauline M. MakiDaniel MerensteinAnandi N. ShethGayle SpringerDavid VanceKathleen M. WeberAnjali Sharma. (2022) Degree of Polypharmacy and Cognitive Function in Older Women with HIV. AIDS Research and Human Retroviruses 38:7, pages 571-579.
Crossref
Crossref
Romain Salle, Constance Mayslich, Philippe Alain Grange, Valentin Leducq, Guillaume Ollagnier, Ugo Heller, Julie Saule, Pervenche Martinet, Jean-Luc Robert, Nadjet Benhaddou, Sebastien Fouere & Nicolas Dupin. (2022)
Specific detection of
Treponema pallidum
in clinical samples: validation of a qPCR assay combining two genomic targets
. Sexually Transmitted Infections, pages sextrans-2021-055364.
Crossref
Crossref
Mohammed I. Danjuma, Oyelola A. Adegboye, Ahmed Aboughalia, Nada Soliman, Ruba Almishal, Haseeb Abdul, Mohamad Faisal Hamad Mohamed, Mohamed Nabil Elshafie, Abdulatif AlKhal, Abdelnaser Elzouki, Arwa Al-Saud, Mas Chaponda & Mubarak Arriyo Bidmos. (2022) Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis. Therapeutic Advances in Drug Safety 13, pages 204209862210807.
Crossref
Crossref
MM Murray, J Lin, A Buros Stein, ML Wilcox, J Cottreau, M Postelnick & FJ Palella. (2021) Relationship of polypharmacy to HIV RNA suppression in people aged ≥ 50 years living with HIV. HIV Medicine 22:8, pages 742-749.
Crossref
Crossref
Zuhal Yeşilbağ, Emine İlay Şengül, Sevtap Şenoğlu, Özlem Altuntaş Aydın & Hayat Kumbasar Karaosmanoğlu. (2020) Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors. Current HIV Research 18:6, pages 415-425.
Crossref
Crossref
Huan Xia, Liying Gao, Xiaowen Gong, Silvere D. Zaongo, Tong Zhang, Hao Wu, Ping Ma & Xiaojie Huang. (2020) The Challenge of Potential Drug–Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China. Frontiers in Pharmacology 11.
Crossref
Crossref
Mira A. Donaldson, Amber R. Campbell, Arianne Y. Albert, Mahtab Borhani, Ariel Nesbitt, Hélène C.F. Côté, Evelyn J. Maan, Neora Pick & Melanie C.M. Murray. (2019) Comorbidity and polypharmacy among women living with HIV in British Columbia. AIDS 33:15, pages 2317-2326.
Crossref
Crossref
Mariam Mama Djima, Didier Koumavi Ekouevi, Jean-Pierre Gregoire, Boris Tchounga, Patrick Ahuatchi Coffie, Viet-Thi Tran, Franck Y. Touré & Jocelyne Moisan. (2019) Use of non-HIV medication among people living with HIV and receiving antiretroviral treatment in Côte d’Ivoire, West Africa: A cross-sectional study. PLOS ONE 14:9, pages e0221335.
Crossref
Crossref
Julian Falutz, Susan Kirkland & Giovanni Guaraldi. 2021. Neurocognitive Complications of HIV-Infection. Neurocognitive Complications of HIV-Infection
301
327
.
Gaelen P. Adam, Mengyang Di, Susan Cu-Uvin, Christopher Halladay, Bryant T. Smith, Suchitra Iyer & Thomas A. Trikalinos. (2018) Strategies for improving the lives of US women aged 40 and above living with HIV/AIDS: an evidence map. Systematic Reviews 7:1.
Crossref
Crossref
Kendra K. Radtke, Peter Bacchetti, Kathryn Anastos, Daniel Merenstein, Howard Crystal, Roksana Karim, Kathleen M. Weber, Andrew Edmonds, Anandi N. Sheth, Margaret A. Fischl, David Vance, Ruth M. Greenblatt & Leah H. Rubin. (2018) Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 78:2, pages 202-208.
Crossref
Crossref
Krista J. Siefried, Limin Mao, Lucette A. Cysique, John Rule, Michelle L. Giles, Don E. Smith, James McMahon, Tim R. Read, Catriona Ooi, Ban K. Tee, Mark Bloch, John de Wit & Andrew Carr. (2018) Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy. AIDS 32:1, pages 35-48.
Crossref
Crossref
Ian R. McNicholl, Monica Gandhi, C. Bradley Hare, Meredith Greene & Edgar Pierluissi. (2017) A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:12, pages 1498-1506.
Crossref
Crossref
Simona A. Iacob, Diana G. Iacob & Gheorghita Jugulete. (2017) Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment—Clinical Points of View and Practical Considerations. Frontiers in Pharmacology 8.
Crossref
Crossref
Janessa M. Smith & Charles Flexner. (2017) The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development. AIDS 31:Supplement 2, pages S173-S184.
Crossref
Crossref
Julian Falutz. 2016. Managing the Older Adult Patient with HIV. Managing the Older Adult Patient with HIV
181
188
.